ንሕማም ረሲዕ ALZHEIMERS DRUG ዝፍውስ መድሃኒት ኣብ ጥቕሚ ክውዕል ጀሚሩ/

Lecanemab is undergoing the regulatory approval process in Australia but the cost means accessibility is an issue_AP.jpg

Credit: AP.jpg

እቲ ኣብ እዋን እርጋን ዘጋጥም ሕማም ረሲዕ (dementia ) ዝከላኸል ናይ መጀመርታ መድሃኒት ኣብ ውሽጢ 30 ዓመት ምምዕባሉ: ንሕሙማት ተስፋ ሂቡ ኣሎ ። [ኣብ መላእ ዓለም ሰፊሕ መርመራ እተገብረሉ መድሃኒት Lecanemab ፡ ነቲ ሕማም ረሲዕነት ዘስዕቦ ጽልዋ ንምዝሓል ዝሕግዝ ናይ መጀመርታ መረጋገጺ ረኺቡ ኣሎ ።] እቲ መድሃኒት ለካነማብ [Lecanemab] ኣብ ኣውስትራልያን ኣብ ካልኦት ሃገራት ዓለምን ናይ ምቁጽጻር መስርሕ ፍቓድ ይካየደሉ እኳ እንተሎ ፡ ኣዝዩ ክቡር ዋጋ ዘኽፍል ብምዃኑ ውሑዳት ሰባት ጥራይ ክረኽብዎ ዝኸውን ከይከውን ተሰጊኡ ኣሎ ።



Share
Follow SBS Tigrinya

Download our apps
SBS Audio
SBS On Demand

Listen to our podcasts
Independent news and stories connecting you to life in Australia and Tigrinya-speaking Australians.
Ease into the English language and Australian culture. We make learning English convenient, fun and practical.
Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service